Meet Zach, who shares his story of living with myasthenia gravis (MG). Zach discusses the challenges of delayed diagnosis, the cost of care, and how redefining his “new normal” has allowed him to find purpose and continue thriving.
Meet Valerie, who shares her story of living with phenylketonuria (PKU). Valerie discusses the challenges of managing the condition throughout her life and the emotional, physical, and systemic barriers that impact daily care.
Meet Tracy, who shares her story of living with thalassemia. Tracy discusses the realities of managing the condition over a lifetime and the impact it has had on her health, her family, and daily life.
After years of trying, Congress is finally on the verge of passing legislation aimed at lowering prescription drug prices by targeting the intermediaries that help negotiate them.
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
On January 27, 2026, the Centers for Medicare and Medicaid Services (CMS) announced the list of drugs selected for the third round of the Medicare Drug Price Negotiation Program.
For decades, pharmacists and pharmacy technicians have served as your trusted providers of vaccine care. New vaccine recommendations may seem confusing, but your pharmacist is ready to help.
Pharmacists are trained health care providers who can explain which vaccines are recommended for you based on your age and other health needs. Pharmacists use their clinical training and the latest scientific information to guide you and your family. Pharmacists can give vaccines to both children and adults. Some states have rules that limit which vaccines and at what ages.
Meet Nicki, who shares her story of living with Excessive Daytime Sleepiness (EDS). Nicki discusses the daily impacts of dealing with the rare disease and the physical and social implications is causes.
On Jan. 22, the House Energy & Commerce Health Subcommittee and House Ways & Means Committee held hearings with the Chief Executives of five major health insurers. With a focus on affordability, Members and witnesses each shared a series of questions, proposals, and commitments regarding the increasing costs of care in the United States. And while health policy proposals continue to face partisan gridlock in Congress, legislators on both sides of the aisle agreed that health insurance premiums have risen exponentially, while increasing rates of prior authorization denials hamper patient access to care.
On Tuesday, Jan. 20, the House appropriators unveiled a three-part minibus spending package for Fiscal Year 2026. The package covers appropriations for the Department of Labor, Department of Health and Human Services (HHS), Department of Defense, Department of Transportation, and Department of Homeland Security. In addition to appropriations funding, the proposal includes several policy changes such as long-term extensions of expiring Medicare telehealth flexibilities and community health center funding, health care program reauthorizations, and significant pharmacy benefit manager (PBM) reform proposals extending to both Medicare and commercial plans.
